Clinical Trial Update: hCT-MSC Infusion in Adults With Autism Spectrum Disorder [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the safety of hCT-MSC infusion in adults with Autism Spectrum Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• hCT-MSC infusion

Snippet

Sponsor: Joanne Kurtzberg, MD | Conditions: Autism Spectrum Disorder, Autism | Phase 1 | Status: COMPLETED